Live news related to FERMENTALG stock (FR0011271600): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on FERMENTALG mainly cover earnings publications et M&A activity. The stock trades at €0,50 on Euronext Paris, up 2,05% at the last update. This page lists the articles published on FERMENTALG stock to track the share price, company announcements and any item likely to influence market perception.
Fermentalg announced on Tuesday the launch of a capital increase of approximately 10 million euros aimed at accelerating the commercialization of its …
Fermentalg achieved a revenue of €3.7 million in the first quarter of 2026, surpassing the previous record from early 2025 (€3.6 million). This perfor…
Fermentalg continued its growth in 2025 with a revenue of €13.4 million, marking a 16% increase despite an unfavorable context characterized by geopol…
Fermentalg significantly rose this Monday mid-session, recording a 4.66% increase to €0.5390, amidst a downward trending Parisian market. The Bordeaux…
Fermentalg ended 2025 with a record revenue of €13.4M, up by 17%, due to diversifying its clientele beyond dietary supplements. However, the company r…
This Monday morning, Fermentalg recorded a significant increase of 5.97%, bringing its stock price to 0.4795 euros during the session. This rebound oc…
Fermentalg announces the positive opinion from the European Food Safety Authority (EFSA) on its natural blue dye Galdieria Blue, derived from the micr…
French biotech company Fermentalg closed the year 2025 with a record revenue of 13.4 million euros, surpassing its initial target of 13 million euros.…
Fermentalg will hold a webinar open to individual investors on January 28, 2026, at 5:30 PM, according to a press release issued last Friday. The comp…
Fermentalg, specializing in BioSolutions based on aquatic microorganisms, announced a stable revenue as of the end of September 2025.
